Clinical trial · Interventional
Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men
NCT03869216CI-TRIAL-00099739completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while the other half will receive usual care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational Shared Decision-Making Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Patients in the intervention will receive the educational intervention
- interventionNames
- Behavioral: Educational Shared Decision-Making Intervention
- type
- NO_INTERVENTION
- label
- Usual Care
- description
- Patients in the control arm will receive usual care
Primary outcomes (1)
- measure
- Shared Decision-making
- timeFrame
- One month after audio-recorded visit
- description
- The Observing Patient Involvement (OPTION) Scale was used for the coding of the SDM. The total OPTION scale ranges from 0 to 48. Higher values on the scale mean higher patient involvement in the decision-making process.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
- Maximum age
- 69 Years
Show eligibility criteria text
Patient Inclusion Criteria: * Receiving care at the clinical sites * Identify as African American male * Ages 40-69 years old Patient Exclusion Criteria: * Personal history of prostate cancer at the time of consent * Cognitive impairment that would interfere with participation in the study * Unable to complete any aspect of the intervention within the specified time limit
References
Publications (0)
Data not yet available
No reference posted for this study.